Fed. Circ. Lifts Sales Ban On Generic Lovenox
By Scott Flaherty ( August 3, 2012, 7:57 PM EDT) -- The Federal Circuit on Friday overturned an injunction blocking Amphastar Pharmaceuticals Inc. and Watson Pharmaceuticals Inc. from selling a generic version of the blood thinner Lovenox after finding that the companies did not likely infringe a Momenta Pharmaceuticals Inc. patent....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.